Assessment of Airway Wall Contrast Enhancement Using Virtual Monoenergetic Imaging from Spectral CT

Overview

This study evaluated lung parenchyma and airway wall attenuation using virtual monoenergetic imaging (VMI) from spectral CT across different contrast phases in lung-healthy individuals. The spectral attenuation curve slope (λHU) was quantified to assess contrast enhancement, demonstrating potential for improved characterization of inflammatory airway diseases.

Background

Quantitative CT post-processing is established for assessing lung and airway abnormalities in diseases like pulmonary fibrosis, cystic fibrosis, asthma, and COPD. Inflammatory changes can be reversible and are indirectly measured by lung density and airway wall dimensions, typically on non-enhanced CT to avoid contrast-related measurement alterations. Spectral detector CT enables generation of iodine maps and VMIs, which may allow direct quantification of contrast enhancement in small airway structures, potentially reflecting active inflammation. This study investigates lung and airway wall attenuation as a function of display energy level and contrast phase using spectral CT.

Data Highlights

Key Findings

• Virtual monoenergetic imaging (VMI) from spectral CT allows modulation of energy levels to enhance iodine-dependent attenuation in lung and airway tissues.
• The spectral attenuation curve slope (λHU) can quantify contrast enhancement in lung parenchyma and airway walls across different contrast phases.
• Contrast-enhanced spectral CT phases (pulmonary arterial, systemic arterial, venous) show increased attenuation compared to non-enhanced scans, enabling assessment of inflammatory changes.
• Advanced airway segmentation algorithms mitigate the impact of intravascular contrast on airway wall measurements, allowing reliable comparison of enhancement intensities.
• Quantitative parameters such as mean lung density (MLD), 15th percentile lung density (Perc15), and lung vessel volume (VV) were successfully measured across spectral CT reconstructions.

Clinical Implications

Spectral CT with VMI provides a novel approach to directly quantify airway wall and lung parenchyma contrast enhancement, potentially improving detection and characterization of active inflammation in airway diseases. This technique may complement existing non-enhanced CT assessments by offering additional functional information without requiring multiple acquisitions. Clinicians should consider spectral CT protocols when evaluating inflammatory airway conditions to enhance diagnostic accuracy.

Conclusion

The study demonstrates that spectral detector CT with virtual monoenergetic imaging enables quantification of airway wall and lung parenchyma contrast enhancement, offering a promising tool for assessing inflammatory airway diseases. Further research may establish its role in clinical practice for monitoring disease activity and response to therapy.

References

1. Various Authors/Multiple Studies (2017-2020) -- Quantitative CT and Spectral Imaging in Lung Disease